Mesa Labs Reports Record Net Income and Revenues LAKEWOOD,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Mesa Labs Reports Record Net Income and Revenues

LAKEWOOD, Colo., June 02, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB ) (we, us, our, “Mesa” or the “Company”) today reported record net income and revenues for both the quarter and the year ended March 31, 2016.

Highlights for the quarter and year ended March 31, 2016 as compared to the same periods last year:  

  • Revenues increased 34 and 19 percent, respectively
  • Non-GAAP adjusted net income 1 increased 70 and 23 percent, respectively
  • Operating income increased 39 and three percent, respectively
  • Net income increased 78 and 17 percent, respectively

Revenues for the fourth quarter increased 34 percent to $24,812,000 as compared to $18,560,000 for the same quarter last year.  Operating income for the fourth quarter increased 39 percent to $5,843,000 as compared to $4,202,000 for the same quarter last year.  Net income for the fourth quarter increased 78 percent to $3,991,000 or $1.06 per diluted share of common stock as compared to $2,239,000 or $0.61 per diluted share of common stock for the same quarter last year.  Net income for the fourth quarter was impacted by a $101,000 reduction in income tax expense which resulted from the adoption of a new accounting standard which requires excess tax benefits and deficiencies associated with share-based payment awards to employees to be accounted for as income tax benefit (expense) as compared to the same quarter in the previous year whereby they were accounted for as an increase (decrease) to equity.

Revenues for the year ended March 31, 2016 increased 19 percent to $84,659,000 as compared to $71,330,000 last year.  Operating income for the year ended March 31, 2016 increased three percent to $16,323,000 as compared to $15,864,000 last year. Net income for the year ended March 31, 2016 increased 17 percent to $11,169,000 or $2.97 per diluted share of common stock as compared to $9,583,000 or $2.63 per diluted share of common stock last year. Operating income and net income for the year ended March 31, 2016 were impacted by an unusual item consisting of $1,709,000 expense, before tax, related to a litigation settlement associated with the Amega Acquisition.  Net income for the year ended March 31, 2016 was also impacted by an $860,000 reduction in income tax expense as discussed above.  Operating income and net income for the year ended March 31, 2015 were impacted by an unusual item consisting of $460,000 (before tax) of expenses associated with uncollected sales tax liabilities. 

On a non-GAAP basis, adjusted net income (which excludes the non-cash impact of amortization of intangible assets, net of tax) for the fourth quarter increased 70 percent to $4,973,000 or $1.33 per diluted share of common stock as compared to $2,930,000 or $0.80 per diluted share of common stock for the same quarter last year.  Adjusted net income for the year ended March 31, 2016 increased 23 percent to $15,324,000 or $4.08 per diluted share of common stock as compared to $12,502,000 or $3.43 per diluted share of common stock last year.  Adjusted net income for years ended March 31, 2016 and 2015 was impacted by the same items noted above.

“The fourth quarter is usually Mesa’s strongest quarter, but in fiscal year 2016 it was extraordinary,” said John J. Sullivan, President and Chief Executive Officer.  “Not only did we break single quarter records for revenues and profits, but the strong finish resulted in new annual records for these performance metrics, as well.  Certainly, a portion of the record results were due to ERP-related delays in shipments during the previous quarter, as mentioned in last quarter’s release, but we also received record new orders in the fourth quarter.  The strategic acquisitions we completed during the fiscal year, including two during the fourth quarter, helped drive revenues to new records for the quarter and year, but equally important was 17 percent of organic growth in the fourth quarter.  For the year, organic growth was a healthy five percent for our combined Instruments and Biological Indicators divisions, which was partially offset by a slight decline in the Continuous Monitoring division of one percent.  I am especially pleased with Mesa’s underlying profitability for both the fourth quarter and the full year.  During the quarter, adjusted net income (“ANI”) was 20 percent of revenues, which equaled our goal.  For the full fiscal year, excluding the unusual expenses in both fiscal years 2016 and 2015, and the fourth quarter accounting standard change that are mentioned above, ANI would have increased 19 percent for the year, representing 18 percent of revenues.  Overall, Mesa’s fourth quarter was a great finish to another record year for Mesa.”

“I am very pleased with the progress we made during fiscal year 2016,” continued John Sullivan.  “We have grown revenues by 19 percent, while improving underlying profitability, implemented a new state-of-the-art ERP system, entered new markets, introduced new products and expanded our international reach.  While I do not expect the first quarter of fiscal year 2017 to match the stellar fourth quarter results (which is consistent with previous years), the business has very good momentum and I do believe that fiscal year 2017 will be another year of excellent growth for both revenues and profits at Mesa.  We will continue to focus our efforts on improving our distribution channels, we will be introducing several important new products and we are hopeful that we will expand the business through strategic acquisitions.  Our progress during fiscal year 2016 and excellent prospects for fiscal year 2017 are a testament to the hard work and dedication of the nearly 400 talented individuals at Mesa, and I would like to thank them for their efforts.”

1 The non-GAAP measures of adjusted net income and adjusted net income per diluted share are defined to exclude the non-cash impact of amortization of intangible assets, net of tax. A reconciliation between these non-GAAP measures and their GAAP counterparts is set forth in the table below, along with additional information regarding their use.

Financial Summary (Unaudited, except for the information as of and for the years ended March 31, 2016 and 2015)

Consolidated Statements of Income
       
(Amounts in thousands, except per share data)   Three Months Ended March 31, Year Ended March 31,
      2016     2015     2016     2015  
Revenues   $ 24,812   $ 18,560   $ 84,659   $ 71,330  
Cost of revenues     9,816     7,048     33,246     27,938  
  Gross profit     14,996     11,512     51,413     43,392  
Operating expenses     9,153     7,310     35,090     27,528  
  Operating income     5,843     4,202     16,323     15,864  
Other expense, net     (58 )   (203 )   (768 )   (517 )
  Earnings before income taxes     5,785     3,999     15,555     15,347  
Income taxes     1,794     1,760     4,386     5,764  
  Net income   $  3,991   $   2,239   $ 11,169   $   9,583  
           
Net income per share (basic)   $  1.10   $   0.63   $    3.10   $   2.72  
Net income per share (diluted)     1.06     0.61     2.97     2.63  
           
Weighted average common shares outstanding:          
Basic     3,630     3,542     3,605     3,521  
Diluted     3,751     3,657     3,757     3,650  
Consolidated Balance Sheets
(Amounts in thousands)   March 31, 2016 March 31, 2015
Cash and cash equivalents   $    5,695   $   2,034  
Other current assets     31,491     27,588  
  Total current assets     37,186     29,622  
Property, plant and equipment, net     16,628     9,598  
Other assets     106,934     78,100  
  Total assets   $ 160,748   $ 117,320  
       
Liabilities   $  76,070   $   43,841  
Stockholders’ equity     84,678     73,479  
  Total liabilities and stockholders’ equity   $ 160,748   $ 117,320  
Reconciliation of Non-GAAP Measures
(Unaudited) 
(Amounts in thousands, except per share data)   Three Months Ended March 31, Year Ended March 31,
      2016     2015     2016     2015   
Net income   $ 3,991   $ 2,239   $ 11,169   $   9,583  
Amortization of intangible   assets, net of tax     982     691     4,155     2,919  
Adjusted net income   $ 4,973   $ 2,930   $ 15,324   $ 12,502  
           
Adjusted net income per share (basic)   $   1.37   $   0.83   $   4.25   $   3.55  
Adjusted net income per share (diluted)     1.33     0.80     4.08     3.43  
           
Weighted average common shares outstanding:          
Basic     3,630     3,542     3,605     3,521  
Diluted     3,751     3,657     3,757     3,650  

 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Compensation—Stock Compensation (Topic 718) , as part of its simplification initiative, which affects all entities that issue share-based payment awards to their employees. The amendments in this update cover such areas as the recognition of excess tax benefits and deficiencies, the classification of those excess tax benefits on the statement of cash flows, an accounting policy election for forfeitures, the amount an employer can withhold to cover income taxes and still qualify for equity classification and the classification of those taxes paid on the statement of cash flows. The ASU was effective for our fiscal year ending March 31, 2018 using either the prospective, retrospective or modified retrospective transition method, depending on the area covered in this update. As permitted within the amendment, we elected to early adopt and prospectively apply the provisions of this amendment as of April 1, 2015.  As a result of the adoption of this ASU, our net income and adjusted net income results by quarter for the year ended March 31, 2016 are as follows (Unaudited, except for the net income amounts for the year ended March 31, 2016):

(Amounts in thousands, except per share data)   Q1  Q2 Q3 Q4 Total
Net income   $ 2,755   $ 1,826   $ 2,597   $   3,991   $ 11,169  
Adjusted net income   $ 3,748   $ 2,799   $ 3,804   $ 4,973   $ 15,324  
             
Net income per share (basic)   $   0.77   $   0.51   $   0.72   $   1.10   $   3.10  
Net income per share (diluted)       0.74      0.48     0.69     1.06     2.97  
             
Adjusted net income per share (basic)   $   1.05   $   0.78   $  1.05   $   1.37   $   4.25  
Adjusted net income per share (diluted)     1.01     0.74     1.00     1.33     4.08  
                                 

Our income tax rate varies based upon many factors but in general, we anticipate that on a go forward basis, our effective tax rate will approximate 33 to 36 percent, plus or minus the impact of excess tax benefits and deficiencies associated with share-based payment awards to employees (which may vary significantly from year to year). 

The non-GAAP measures of adjusted net income and adjusted net income per share presented in the reconciliation above are defined to exclude the non-cash impact of amortization of intangible assets, net of tax. The tax effect is calculated using the average corporate rate for that period multiplied by the amortization. We believe that excluding these acquisition related expenses provides the ability to understand the benefits of acquisitions based on their cash return.

We provide non-GAAP adjusted net income and non-GAAP adjusted net income per share amounts in order to provide meaningful supplemental information regarding our operational performance. Our management uses non-GAAP measures to evaluate the performance of our business and to compensate employees. This information facilitates management's internal comparisons to our historical operating results as well as to the operating results of our competitors. Since management finds this measure to be useful, we believe that our investors can benefit by evaluating both non-GAAP and GAAP results.

Our management recognizes that items such as amortization of intangible assets can have a material impact on our net income. To gain a complete picture of all effects on our profit and loss from any and all events, management does (and investors should) rely upon the GAAP consolidated statements of income. The non-GAAP numbers focus instead upon our core operating business.

Readers are reminded that non-GAAP measures are merely a supplement to, and not a replacement for, or superior to financial measures prepared according to GAAP. They should be evaluated in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

About Mesa Laboratories, Inc.

We pursue a strategy of focusing primarily on quality control products and services, which are sold into niche markets that are driven by regulatory requirements. We prefer markets that have limited competition where we can establish a commanding presence and achieve high gross margins.  We are organized into four divisions across eight physical locations.  Our Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries.  Our Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries.  Our Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments. Our Cold Chain Division provides parameter (primarily temperature) monitoring of products in a cold chain, consulting services such as compliance monitoring, packaging development and validation or mapping of transport and storage containers, and thermal packaging products such as coolers, boxes, insulation materials and phase-change products to control temperature during transport.

Forward Looking Statements This press release may contain information that constitutes "forward-looking statements." Generally, the words "believe," "expect," "project," “anticipate,” “intend,” "estimate," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to revenue growth and statements expressing general views about future operating results — are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections. These risks and uncertainties include, but are not limited to, those described in our Annual Report on Form 10-K for the year ended March 31, 2015, and those described from time to time in our subsequent reports filed with the Securities and Exchange Commission.

For more information about the Company, please visit its website at www.mesalabs.com .

CONTACT: John J. Sullivan, Ph.D.; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 191

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading

Top 5 Most Recently Viewed Articles

MSG Entertainment Reports Q1 Results for Fiscal 2025

Updated Category News Views 259

MSG Entertainment's Strong Start to Fiscal 2025 Madison Square Garden Entertainment Corp. (NYSE: MSGE) has released its financial results for the first quarter of fiscal 2025, providing insight into its performance and future expectations. The company, known for its impressive entertainment offerings, has experienced a robust period marked by several noteworthy...

Continue Reading
Asia Pacific Consumer Trends 2025: Emphasizing Intentional Spending

Updated Category News Views 1304

Embracing Intentional Spending in Asia Pacific NielsenIQ (NIQ), the foremost global consumer intelligence company, has published its Mid-Year Consumer Outlook (MYCO) report highlighting a significant transition among Asia Pacific consumers. This report underscores how consumers are moving away from cautious spending towards more intentional and purpose-driven consumption....

Continue Reading
BILL Holdings Sees Stock Surge as Investor Takes 8% Share

Updated Category News Views 303

Stock Rise for BILL Holdings Inc BILL Holdings Inc (NYSE: BILL) has experienced a noticeable surge in its stock price during after-hours trading recently. This uptick follows reports indicating that the activist investment firm Starboard Value has acquired an 8% stake in the company. Overview of the Recent Developments After hours, BILL stock showed signs of strength,...

Continue Reading
Saudi Fund for Development Fuels Growth in Serbia with $205M Deals

Updated Category News Views 84

Saudi Fund for Development Boosts Economic Growth in Serbia The Saudi Fund for Development (SFD) is making significant strides in fostering growth in Serbia through the signing of three major development loan agreements, totaling $205 million. This initiative marks the Fund's first venture into Serbia, reflecting its commitment to promoting sustainable development across...

Continue Reading
Chevron's 2025 Capex Budget and Strategic Update Overview

Updated Category News Views 487

Chevron's Strategic Vision for 2025 Capex Budget Chevron Corporation has announced its ambitious 2025 capital expenditure budget, setting the range between $14.5 to $15.5 billion for its consolidated subsidiaries, alongside an affiliate capex range of $1.7 to $2.0 billion. This capex approach emphasizes Chevron's commitment to operational excellence and enhanced...

Continue Reading